DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Schwab N, Schneider-Hohendorf T, Pignolet B. , et al.
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values.
Neurol Neuroimmunol Neuroinflamm 2016;
3 (01) e195
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.